Skip to main content

Table 2 In-hospital treatment and events in 1062 patients with acute coronary syndrome

From: Long-term clinical outcome in patients with acute coronary syndrome and dysglycaemia

 

NGT

IFG/IGT

DiabetesA

DiabetesB

P

No.

295

299

156

312

 

Female/male (n)

76/219

77/222

40/116

88/224

NS

Coronary angiography  %

92.5 (273)l

94.0 (281)l

92.3 (144)l

73.7 (230)c,f,i

<0.001

 Coronary angio-graphy in 928 patients

  PCI  % (of 928)

70.7 (193)l

66.5 (187)l

69.4 (100)l

57.4 (132)c,f,i

<0.05

  PCI in 612 patients

   Stent  % (of 612)

87.0 (168)

87.7 (164)

87.0 (87)

89.4 (118)

NS

   Stent in 537 patients

     

    BMS %

81.5 (137)l

82.9 l (136)

81.6 (71)l

60.2 (71)c,f,i

<0.001

    DES %

18.5 (31)l

17.1l (28)

18.4 (16)l

39.8 (47)c,f,i

<0.001

CABG  %

13.9 (41)

16.7 (50)

16.7 (26)

17.9 (56)

NS

LVEF evaluation  %

83.4 (246)l

83.3 (249)l

87.2 (136)l

76.0 (237)c,f,i

<0.001

Normal LVEF (>50 %)

74.4 (183)l

72.3 (180)l

67.6 (92)l

50.6 (120)c,f,i

<0.001

Reduced LVEF (<50 %)

25.6 (63)l

27.7 (69)l

32.4 (44)l

49.4 (117)c,f,i

<0.001

  1. Parenthesis show number of individuals
  2. PCI percutaneous coronary intervention, BMS bare metal stents, DES drug-eluting stents, CABG coronary artery bypass graft, LVEF left ventricular ejection fraction
  3. vs NGT, ap < 0.05, b p < 0.01, c p < 0.001; vs IFG/IGT, d p < 0.05, p < 0.01, p < 0.001; vs Diabetes OGTT, g p < 0.05, p < 0.01, i p < 0.001; vs known diabetes, j p < 0.05, p < 0.01, p < 0.001
  4. APatients with diabetes discovered by OGTT
  5. BPatients with known diabetes at admission